Delving into the Latest Updates on Biomedical Research Institute of Jiangsu Wuzhong Medicine Group Co., Ltd. with Synapse

Overview

Tags

Respiratory Diseases

Neoplasms

Recombinant protein

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Recombinant protein	1

Top 5 Target	Count

Protein kinases	1

The primary objective was to investigate the tolerability of single and multiple intravenous infusions of recombinant human endostatin injection in Chinese patients with advanced solid tumors. The secondary objective was to evaluate the pharmacokinetic characteristics of single and multiple intravenous infusions of recombinant human endostatin injection in Chinese patients with advanced solid tumors.

Start Date12 Dec 2016

Sponsor / Collaborator

Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.

[+1]

CTR20131255 / Active, not recruitingPhase 3

重组人血管内皮抑素注射液联合NP对照安慰剂联合NP治疗初治晚期非小细胞肺癌患者的三期临床研究

[Translation] Phase III clinical study of recombinant human endostatin injection combined with NP versus placebo combined with NP in the treatment of patients with newly diagnosed advanced non-small cell lung cancer

评价重组人血管内皮抑素注射液联合长春瑞滨/顺铂（NP）化疗方案较单纯NP方案在治疗IV期非小细胞肺癌病人（UICC 第7版NSCLC分期定义）的临床生存期获益优势。观察重组人血管内皮抑素注射液联合化疗方案在晚期非小细胞肺癌病人中的安全性。

[Translation]

To evaluate the clinical survival benefit of recombinant human endostatin injection combined with vinorelbine/cisplatin (NP) chemotherapy compared with NP alone in the treatment of patients with stage IV non-small cell lung cancer (UICC 7th edition NSCLC staging definition). To observe the safety of recombinant human endostatin injection combined with chemotherapy in patients with advanced non-small cell lung cancer.

Start Date10 Nov 2011

Sponsor / Collaborator

Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.

[+1]

100 Clinical Results associated with Biomedical Research Institute of Jiangsu Wuzhong Medicine Group Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Biomedical Research Institute of Jiangsu Wuzhong Medicine Group Co., Ltd.

Login to view more data

100 Deals associated with Biomedical Research Institute of Jiangsu Wuzhong Medicine Group Co., Ltd.

Login to view more data

100 Translational Medicine associated with Biomedical Research Institute of Jiangsu Wuzhong Medicine Group Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3 Clinical

1

Login to view more data